Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 494,006 |
|
|||||
| News | - | ||||||
| Day High | 74.29 | Low High |
|||||
| Day Low | 71.15 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Axsome Therapeutics Inc | AXSM | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 1.12 | 1.54% | 73.63 | 23:00:07 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 72.11 | 71.15 | 74.29 | 73.63 | 72.51 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,374 | 494,006 | US$ 72.91 | US$ 36,018,771 | - | 55.02 - 98.40 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:17:27 | 4 | US$ 74.23 | USD |
Axsome Therapeutics (AXSM) Options Flow Summary
Axsome Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.49B | 47.37M | - | 270.6M | -239.24M | -5.05 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Axsome Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AXSM Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 74.38 | 75.85 | 64.11 | 71.62 | 1,259,504 | -0.75 | -1.01% |
| 1 Month | 77.48 | 79.13 | 64.11 | 73.51 | 739,924 | -3.85 | -4.97% |
| 3 Months | 81.52 | 83.8899 | 64.11 | 73.65 | 637,672 | -7.89 | -9.68% |
| 6 Months | 76.05 | 98.40 | 64.11 | 78.46 | 701,050 | -2.42 | -3.18% |
| 1 Year | 74.94 | 98.40 | 55.02 | 75.06 | 748,117 | -1.31 | -1.75% |
| 3 Years | 66.39 | 98.40 | 19.38 | 54.29 | 986,457 | 7.24 | 10.91% |
| 5 Years | 22.91 | 125.25 | 13.64 | 56.20 | 867,730 | 50.72 | 221.39% |
Axsome Therapeutics Description
| Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. |
